BackgroundAtrial fibrillation (AF) is a cause of stroke, and undertreatment with anticoagulants is a persistent issue despite their effectiveness.
AimTo increase the proportion of people with AF treated appropriately using anticoagulants, and reduce inappropriate antiplatelet therapy.
Design of studyCross-sectional analysis.
SettingElectronic patient health records on 4604 patients with AF obtained from general practices in three inner London primary care trusts between April 2011 and 2013.
MethodThe Anticoagulant Programme East London (APEL) sought to achieve its aims through an intervention with three components: altering professional beliefs using new clinical guidance and related education; facilitating change using computer software to support clinical decisions and patient review optimising anticoagulation; motivating change through evaluative feedback showing individual practice performance relative to peers.
ResultsFrom April 2011 to April 2013, the proportion of people with CHA 2 DS 2 -VASc ≥1 on anticoagulants increased from 52.6% to 59.8% (trend difference P<0.001). The proportion of people with CHA 2 DS 2 -VASc ≥1 on aspirin declined from 37.7% to 30.3% (trend difference P<0.001). Comparing the 2 years before the intervention with the 2 years after, numbers of new people on the AF register almost doubled from 108 to 204.
ConclusionsThe APEL programme supports improvement in clinical managing AF by a combined programme of education around agreed guidance, computer aids to facilitate decisionmaking and patient review and feedback of locally identifiable results. If replicated nationally over 3 years, such a programme could result in approximately 1600 fewer strokes every year.